Skip to content

Maze Therapeutics

US · MAZE #2998 by market cap Listed 2025
31.37 -1.06 -3.27%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
A-
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 9 analysts

Buy
Avg price target 61.78 +96.9%
Price target rangecurrent 31.37
Low46.00
Avg61.78
High110.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-11 J.P. Morgan -- Buy 51.00
2026-11-10 CCORF -- Buy 75.00
2026-11-10 Wells Fargo -- Buy 55.00
2026-11-10 H.C. Wainwright -- Buy 110.00
2026-11-09 BTIG -- Buy 46.00
2026-11-09 Citi -- Buy 50.00
2026-11-09 J.P. Morgan -- Buy --
2026-10-26 H.C. Wainwright -- Buy 110.00
2026-10-26 J.P. Morgan -- Buy --
2026-10-23 Citi -- Buy 50.00
2026-10-20 H.C. Wainwright -- Buy 110.00
2026-10-19 CCORF -- Buy 75.00
2026-10-15 Wells Fargo -- Buy 55.00
2026-10-05 H.C. Wainwright -- Buy 110.00
2026-09-23 Wedbush -- Buy 48.00
2026-09-23 Citi -- Buy 50.00
2026-09-22 LifeSci Capital -- Buy 57.00
2026-09-22 BTIG -- Buy 46.00
2026-09-22 Truist Financial -- Buy 64.00
2026-09-22 H.C. Wainwright -- Buy 110.00
2026-09-09 Wells Fargo -- Buy 55.00
2026-08-13 Truist Financial -- Buy 64.00
2026-08-12 Wells Fargo -- Buy 55.00
2026-08-12 LifeSci Capital -- Buy 57.00
2026-08-12 Wedbush -- Buy 48.00

Price target trend monthly average, last 3 years

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Maze Therapeutics discussion 0 comments

Add a comment